Egetis Therapeutics AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	164	181	127	121	90	110
Market Cap Growth	2.10%	42.41%	5.06%	34.09%	-17.74%	27.08%
Enterprise Value	159	180	121	106	77	96
Last Close Price	0.41	0.51	0.43	-	-	-
PS Ratio	37.42	54.55	28.34	67.42	29.00	30.33
PB Ratio	7.47	5.10	2.99	3.01	2.10	1.96
P/TBV Ratio	7.54	5.14	3.02	3.04	2.13	1.98
EV/Sales Ratio	34.98	54.16	26.91	59.07	24.58	26.41
Debt / Equity Ratio	0.33	0.24	0.21	0.01	0.01	0.01
Asset Turnover	0.09	0.06	0.09	0.04	0.06	0.08
Inventory Turnover	45.41	13.65	16.92	219.39	50.34	-
Quick Ratio	0.76	1.83	3.27	2.80	3.85	4.21
Current Ratio	0.80	1.86	3.33	2.98	3.90	4.28
Return on Equity (ROE)	-111.83%	-66.17%	-62.16%	-37.51%	-18.05%	-40.66%
Return on Assets (ROA)	-33.74%	-25.91%	-29.45%	-21.78%	-10.22%	-22.42%
Return on Capital Employed (ROCE)	-91.00%	-54.70%	-47.40%	-38.50%	-19.80%	-27.40%
Earnings Yield	-16.08%	-13.66%	-20.02%	-12.72%	-9.44%	-14.44%
FCF Yield	-11.06%	-9.06%	-17.05%	-11.39%	-11.76%	-10.92%
Buyback Yield / Dilution	-22.32%	-19.57%	-33.86%	-7.97%	-166.96%	-30.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.